Stack Lab

Compare compound mechanisms, evidence quality, related research topics, receptor considerations, and live COA-verified prices. Add 1–5 compounds.

Triple AgonistGHK-Cu

2 of 5 compounds

Research signals

Triple AgonistRich researchBreakout
GHK-CuRich researchBreakout

Receptor Compatibility

Redundancy, true conflicts, and dangerous additive effects

Step 1

Review advised

No documented conflicts — some notes to review

100%Compatible

Full receptor analysis →

Receptor activity map

Receptor	Triple Agon…	GHK-Cu
GLP-1R (Glucagon-like peptide-1 receptor)
GIPR (Glucose-dependent insulinotropic polypeptide receptor)
GcgR (Glucagon receptor)
Y2R (Peptide YY receptor, class A GPCR)
NFκB signaling pathway
Extracellular matrix / collagen synthesis (copper-dependent enzymatic)
cAMP / beta-arrestin (GPCR intracellular signaling)

ActivePartialInactiveUnknown

View full receptor analysis →

Evidence review

A structured review of the evidence for this stack

Step 2

Sign in to build a structured evidence review for Triple Agonist + GHK-Cu — mechanisms, evidence, endpoints, and limitations grounded in documented research.

Create a free account Sign in

Community data

Aggregate research activity for this selection

Step 3

3 researchers have logged this combination on VialTalk

Related research topics in matching journals

+ Human Growth Hormone + Melanotan II

Forum discussions on this stack

Researchers are also adding

+ NAD++ MOTS-c + Tesamorelin + Dual Incretin Agonist + KPV + 5-Amino-1MQ

Pricing snapshot

Best price for each compound today

Step 4

Triple Agonist
from Peptinexia · 24 vendors
Compare all vendors →
8 panels
$21 · 10mg
$2.10/mg
GHK-Cu
from Peptinexia · 22 vendors
Compare all vendors →
5 panels
$21.75 · 50mg
$0.07/mg

Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.

For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.